RE:Current Leadership under Raza Bokhari From a high of .94 with previous leadership. Since he took over, 201/1 split, stock has dropped close to 2 cents and holding even with an uplist. Assets sold and building(trying to sell). More dilution on the way from what has already begun. Raza has done great...lol....speaking of the other guy AD, where he at??? Been quiet since our supposed quiet period well over a year ago. Lawsuits catching up?
BearHunterr wrote: This management is doing a way better job than the 2018 management I’ll tell you that.
Seems like Raza cares about getting the hard work done. There are not shortcuts to FDA Drug Development.